Clinical Trial Update: Neoadjuvant Herceptin in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial of trastuzumab (Herceptin) in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Mothaffar Rimawi | Conditions: BREAST CANCER | Phase 2 | Status: TERMINATED